Home Cart 0 Sign in  
X

[ CAS No. 184416-84-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 184416-84-0
Chemical Structure| 184416-84-0
Chemical Structure| 184416-84-0
Structure of 184416-84-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 184416-84-0 ]

Related Doc. of [ 184416-84-0 ]

Alternatived Products of [ 184416-84-0 ]

Product Details of [ 184416-84-0 ]

CAS No. :184416-84-0 MDL No. :MFCD01861977
Formula : C6H3Cl2NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :VGKZZKKTZKRCPA-UHFFFAOYSA-N
M.W : 192.00 Pubchem ID :2736083
Synonyms :

Calculated chemistry of [ 184416-84-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.22
TPSA : 50.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.07 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.09
Log Po/w (XLOGP3) : 1.97
Log Po/w (WLOGP) : 2.09
Log Po/w (MLOGP) : 0.09
Log Po/w (SILICOS-IT) : 2.04
Consensus Log Po/w : 1.45

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.61
Solubility : 0.472 mg/ml ; 0.00246 mol/l
Class : Soluble
Log S (Ali) : -2.65
Solubility : 0.43 mg/ml ; 0.00224 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.63
Solubility : 0.446 mg/ml ; 0.00232 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.61

Safety of [ 184416-84-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 184416-84-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 184416-84-0 ]
  • Downstream synthetic route of [ 184416-84-0 ]

[ 184416-84-0 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 2402-77-9 ]
  • [ 124-38-9 ]
  • [ 184416-84-0 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -78 - -25℃; for 3 h;
Stage #2: at 20℃; for 18 h;
Stage #3: With hydrogenchloride; water In tetrahydrofuran; diethyl ether; hexane at 0 - 20℃;
2,3-Dichloro-isonicotinic acid[00195] To a solution of diisopropylamine (7.0 niL, 50 mmol) in anhydrous THF (100 rnL) at -25°C was added a 1.6M solution of nBuLi in hexanes (31 rnL, 50 mmol) dropwise under an inert atmosphere. The reaction mixture was then cooled to -78°C and 2,3- dichloropyridine was added. The reaction mixture was stirred at -78°C for 3 hours, then poured onto solid carbon dioxide and aged for 18 hours at room temperature. The mixture was diluted with water (100 mL) and washed with diethyl ether (3 x 40 mL) then cooled to 00C, acidified with concentrated HCl (ca. 5 mL) and extracted with diethyl ether (3 x 50 mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated to give the title compound as a white solid (7.7 g, 80percent). 1H NMR (d6-DMSO, 400MHz) 8.49 (d, J = 5.0 Hz, IH), 7.72 (d, J = 5.0 Hz, IH).
Reference: [1] European Journal of Organic Chemistry, 2001, # 7, p. 1371 - 1376
[2] Patent: WO2009/85980, 2009, A1, . Location in patent: Page/Page column 46
  • 2
  • [ 124-38-9 ]
  • [ 184416-84-0 ]
YieldReaction ConditionsOperation in experiment
83%
Stage #1: With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -78℃; for 2 h;
Stage #2: for 1 h;
Stage #3: With hydrogenchloride In tetrahydrofuran; hexane; water
To a solution of diisopropylamine (21. Gg, 213 mmol) and n-butyllithium in hexane (137 ml, 214 mmol) in tetrahydrofuran (600 ml) was added 2,3-dichloropyridine (30.0 g, 203 mmol) in tetrahydrofuran at -78 0C. After 2 hour stirring, dry ice (100 g) was added and the solution was further stirred for one hour. Resulting white precipitate formed by acidification to pH 1 with 6N hydrochloric acid was collected by filtration and dried to afford 2,3-dichloroisonicotinic acid (32.5 g, 169 mmol, 83percent) as white crystals.
Reference: [1] Patent: WO2006/36015, 2006, A2, . Location in patent: Page/Page column 123
  • 3
  • [ 67-56-1 ]
  • [ 184416-84-0 ]
  • [ 603124-78-3 ]
YieldReaction ConditionsOperation in experiment
96%
Stage #1: With oxalyl dichloride In dichloromethane at 20℃; for 18 h;
Stage #2: at 0 - 20℃;
2,3-Dichloro-isonicotinic acid methyl ester[00197] To a suspension of 2,3-dichloro-isonicotinic acid (7.7 g, 40 mmol) in dichloromethane (45 mL) were added DMF (0.1 mL) and oxalyl chloride (17.5 mL, 200 mmol). The reaction mixture was stirred at room temperature for 18 hours and then concentrated under reduced pressure. The resultant residue was azeotroped with toluene, then cooled to 00C and dissolved in methanol (135 mL). The mixture was allowed to warm to room temperature and then concentrated under reduced pressure to give a residue. The residue was dissolved in ethyl acetate and the resulting solution was washed with a saturated solution of sodium hydrogen carbonate, water and brine, dried (Na2SO4), filtered and concentrated to give the title compound as a colourless oil that crystallised on standing (7.9 g, 96percent). 1H NMR (CDCl3, 400MHz) 8.38 (d, J = 5.0 Hz, IH), 7.52 (d, J = 5.0 Hz, IH), 3.99 (s, 3H).
Reference: [1] Patent: WO2009/85980, 2009, A1, . Location in patent: Page/Page column 46
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 184416-84-0 ]

Chlorides

Chemical Structure| 603124-78-3

[ 603124-78-3 ]

Methyl 2,3-dichloroisonicotinate

Similarity: 0.94

Chemical Structure| 884495-41-4

[ 884495-41-4 ]

2,3-Dichloroisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 41667-95-2

[ 41667-95-2 ]

5,6-Dichloropyridine-3-carboxylicacid

Similarity: 0.80

Chemical Structure| 54718-39-7

[ 54718-39-7 ]

2,5,6-Trichloronicotinic acid

Similarity: 0.79

Chemical Structure| 5398-44-7

[ 5398-44-7 ]

2,6-Dichloroisonicotinic acid

Similarity: 0.79

Carboxylic Acids

Chemical Structure| 41667-95-2

[ 41667-95-2 ]

5,6-Dichloropyridine-3-carboxylicacid

Similarity: 0.80

Chemical Structure| 54718-39-7

[ 54718-39-7 ]

2,5,6-Trichloronicotinic acid

Similarity: 0.79

Chemical Structure| 5398-44-7

[ 5398-44-7 ]

2,6-Dichloroisonicotinic acid

Similarity: 0.79

Chemical Structure| 13958-93-5

[ 13958-93-5 ]

3,5-Dichloroisonicotinic acid

Similarity: 0.78

Chemical Structure| 62774-90-7

[ 62774-90-7 ]

2,6-Dichloro-4-methylnicotinic acid

Similarity: 0.77

Related Parent Nucleus of
[ 184416-84-0 ]

Pyridines

Chemical Structure| 603124-78-3

[ 603124-78-3 ]

Methyl 2,3-dichloroisonicotinate

Similarity: 0.94

Chemical Structure| 884495-41-4

[ 884495-41-4 ]

2,3-Dichloroisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 41667-95-2

[ 41667-95-2 ]

5,6-Dichloropyridine-3-carboxylicacid

Similarity: 0.80

Chemical Structure| 54718-39-7

[ 54718-39-7 ]

2,5,6-Trichloronicotinic acid

Similarity: 0.79

Chemical Structure| 5398-44-7

[ 5398-44-7 ]

2,6-Dichloroisonicotinic acid

Similarity: 0.79